Email Updates2019 National Survey On Drug Use And Health: Women
These reports and detailed tables present estimates from the 2019 National Survey on Drug Use and Health (NSDUH), specifically pertaining to substance use among women.
MAT Tools and Resources
The MAT Tools & Resources Collection is a searchable database of tools and resources available to help those who offer or use MAT services. The tools can be filtered by a number of factors, including use, topic, format, audience, and terms of use. Related to the MAT for OUD Environmental scan publications.
Management of Pain During and After Delivery
This is a toolkit on addressing pain in patients with opioid use disorder (OUD) and managing medication for addiction treatment (MAT) during the perioperative/postpartum period.
Drugs and Lactation Database (LactMed)
The LactMed® database contains information on drugs and other chemicals to which breastfeeding mothers may be exposed. It includes information on the levels of such substances in breast milk and infant blood, and the possible adverse effects in the nursing infant.
Index to Drug-Specific Information
This FDA page provides an index of over 400 FDA approved drugs and their descriptions. Note that it does not include all FDA approved drugs, but shares other resources to find more information on drugs not included on the list.
The Case for Screening and Treatment of Co-Occurring Disorders
SAMHSA offers evidence-based resources to help providers screen, diagnose, and deliver integrated care to patients with co-occurring disorders.
Reducing Polysubstance Use in Pregnancy
In this webinar, Drs. John Iskander and Suzanne Gilboa discuss what CDC and its partners are doing to reduce prenatal substance exposure and how screening and brief interventions may reduce prenatal substance exposure and improve the health of women and infants.
Checklist of Evidence-Based Recommendations for Caring for Pregnant Women with Opioid Use Disorder
The following checklist intends to support health care teams in providing evidence-based recommendations for treating pregnant and postpartum patients with OUD. The checklist is divided into five sections, sequenced by timing of presentation to care.
4Ps Screening Tool for Drug and Alcohol Use
This screening device is often used as a way to begin discussion about drug and alcohol use. Any woman who answers yes to one or more questions should be referred for further assessment.
CRAFFT
This revised version of the CRAFFT screening tool incorporates changes that enhance the sensitivity of this well-validated and widely-utilized adolescent substance use screening tool to accurately identify adolescents at risk for a substance use disorder. It also presents new recommended clinician talking points, informed by the latest science and clinician feedback.
TAPS
The Tobacco, Alcohol, Prescription medication, and other Substance use (TAPS) Tool consists of a combined screening component (TAPS-1) followed by a brief assessment (TAPS-2) for those who screen positive.